New drug tested to keep critically ill patients comfortably sedated
NCT ID NCT06124404
Summary
This study tested a new sedation medication called remimazolam in 36 ICU patients who were on breathing machines. The goal was to see if it could safely keep patients in the desired calm and comfortable state without needing extra rescue drugs. Researchers measured how well and for how long the drug worked, and monitored for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MECHANICALLY VENTILATED PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wuhan Union Hospital
Wuhan, Hubei, 430022, China
Conditions
Explore the condition pages connected to this study.